HOME | OUR COMPANY | PRODUCT PORTFOLIO | PRESS ROOM| INVESTORS | CAREERS | CONTACT US
SITE MAP | TERMS OF USE | PRIVACY POLICY

emergent biosolutions logo
Home Page
Our Company
BusinessDevelopment
ScientificBackground
Technologies
spi-VEC TM
MVAtor TM Executive Management
Board of Directors

Our Company

Emergent BioSolutions Inc. is a biopharmaceutical company focused on the development, manufacture and commercialization of vaccines and therapeutics that assist the body’s immune system to prevent or treat disease. Emergent’s marketed product, BioThrax® (Anthrax Vaccine Adsorbed), is the only vaccine licensed by the U.S. Food and Drug Administration for the prevention of anthrax. Emergent’s development pipeline includes programs focused on anthrax, botulism, tuberculosis, typhoid, hepatitis B and chlamydia.

OUR COMPANY Product Portfolio Press Room INVESTORS CAREERS CONTACT US